Skip to main content
. 2025 Sep 11;16:1657213. doi: 10.3389/fendo.2025.1657213

Table 3.

Subgroup analyses of the effect of LDL-C/HDL-C ratio on stroke.

Subgroup N Events, n(%) HR(95%CI) P for interaction
Sex 0.547
male 5999 308 (5.2) 1.48 (1.24, 1.78)
female 6894 223 (3.2) 1.37 (1.09, 1.72)
Age, years 0.556
<65 6431 183 (2.9) 1.36 (1.08, 1.72)
≥65 6462 348 (5.3) 1.47 (1.23, 1.76)
BMI,kg/m2 0.668
<24 7272 351 (4.8) 1.46 (1.22, 1.75)
≥24 5621 180 (3.2) 1.38 (1.08, 1.76)
Smoking 0.473
never smokers 7549 254 (3.4) 1.36 (1.10, 1.69)
former smokers 1993 86 (4.3) 1.51 (1.10, 2.07)
current smokers 3351 191 (5.7) 1.50 (1.21, 1.86)
Drinking 0.024
never drinkers 8535 308 (3.7) 1.28 (1.06, 1.55)
former drinkers 1628 80 (4.9) 1.56 (1.11, 2.19)
current drinkers 2912 143 (4.9) 1.76 (1.38, 2.25)
Diabetes 0.401
no 10632 421 (4.0) 1.48 (1.25, 1.75)
yes 2261 110 (4.8) 1.30 (0.96, 1.74)
Dyslipidemia 0.957
no 4092 188 (4.6) 1.47 (1.08, 2.00)
yes 8801 343 (3.9%) 1.46 (1.23, 1.74)

Each subgroup analysis adjusted, if not stratified, for sex, age, BMI, WC, SBP, DBP, FPG, TC, TG, eGFR, Hcy, smoking, drinking, diabetes, dyslipidemia, CKD, CHD, AF, antiplatelet drugs, antihypertensive drugs, glucose-lowering drugs. The P-interaction was evaluated against the Bonferroni-corrected α value to minimize the risk of type I error.